RATIONALE: Human rhinoviruses (HRVs) consist of approximately 160 types that cause a wide range of clinical outcomes, including asymptomatic infections, common colds, and severe lower respiratory illnesses. OBJECTIVES: To identify factors that influence the severity of HRV illnesses. METHODS: HRV species and types were determined in 1,445 nasal lavages that were prospectively collected from 209 infants participating in a birth cohort who had at least one HRV infection. Questionnaires were used during each illness to identify moderate to severe illnesses (MSI). MEASUREMENTS AND MAIN RESULTS: Altogether, 670 HRV infections were identified, and 519 of them were solitary infections (only one HRV type). These 519 viruses belonged to 93 different types of three species: 49 A, 9 B, and 35 C types. HRV-A (odds ratio, 8.2) and HRV-C (odds ratio, 7.6) were more likely to cause MSI compared with HRV-B. In addition, HRV infections were 5- to 10-fold more likely to cause MSI in the winter months (P < 0.0001) compared with summer, in contrast to peak seasonal prevalence in spring and fall. When significant differences in host susceptibility to MSI (P = 0.004) were considered, strain-specific rates of HRV MSI ranged from less than 1% to more than 20%. CONCLUSIONS: Factors related to HRV species and type, season, and host susceptibility determine the risk of more severe HRV illness in infancy. These findings suggest that anti-HRV strategies should focus on HRV-A and -C species and identify the need for additional studies to determine mechanisms for seasonal increases of HRV severity, independent of viral prevalence, in cold weather months.
RATIONALE: Human rhinoviruses (HRVs) consist of approximately 160 types that cause a wide range of clinical outcomes, including asymptomatic infections, common colds, and severe lower respiratory illnesses. OBJECTIVES: To identify factors that influence the severity of HRV illnesses. METHODS: HRV species and types were determined in 1,445 nasal lavages that were prospectively collected from 209 infants participating in a birth cohort who had at least one HRV infection. Questionnaires were used during each illness to identify moderate to severe illnesses (MSI). MEASUREMENTS AND MAIN RESULTS: Altogether, 670 HRV infections were identified, and 519 of them were solitary infections (only one HRV type). These 519 viruses belonged to 93 different types of three species: 49 A, 9 B, and 35 C types. HRV-A (odds ratio, 8.2) and HRV-C (odds ratio, 7.6) were more likely to cause MSI compared with HRV-B. In addition, HRV infections were 5- to 10-fold more likely to cause MSI in the winter months (P < 0.0001) compared with summer, in contrast to peak seasonal prevalence in spring and fall. When significant differences in host susceptibility to MSI (P = 0.004) were considered, strain-specific rates of HRV MSI ranged from less than 1% to more than 20%. CONCLUSIONS: Factors related to HRV species and type, season, and host susceptibility determine the risk of more severe HRV illness in infancy. These findings suggest that anti-HRV strategies should focus on HRV-A and -C species and identify the need for additional studies to determine mechanisms for seasonal increases of HRV severity, independent of viral prevalence, in cold weather months.
Authors: Ann C Palmenberg; David Spiro; Ryan Kuzmickas; Shiliang Wang; Appolinaire Djikeng; Jennifer A Rathe; Claire M Fraser-Liggett; Stephen B Liggett Journal: Science Date: 2009-02-12 Impact factor: 47.728
Authors: Wai-Ming Lee; Kris Grindle; Tressa Pappas; David J Marshall; Michael J Moser; Edward L Beaty; Peter A Shult; James R Prudent; James E Gern Journal: J Clin Microbiol Date: 2007-05-30 Impact factor: 5.948
Authors: Neil Renwick; Brunhilde Schweiger; Vishal Kapoor; Zhiqiang Liu; Joseph Villari; Reinhard Bullmann; Robert Miething; Thomas Briese; W Ian Lipkin Journal: J Infect Dis Date: 2007-12-15 Impact factor: 5.226
Authors: Susanna K P Lau; Cyril C Y Yip; Ada W C Lin; Rodney A Lee; Lok-Yee So; Yu-Lung Lau; Kwok-Hung Chan; Patrick C Y Woo; Kwok-Yung Yuen Journal: J Infect Dis Date: 2009-10-01 Impact factor: 5.226
Authors: E Kathryn Miller; Kathryn M Edwards; Geoffrey A Weinberg; Marika K Iwane; Marie R Griffin; Caroline B Hall; Yuwei Zhu; Peter G Szilagyi; Laura-Lee Morin; Luke H Heil; Xiaoyan Lu; John V Williams Journal: J Allergy Clin Immunol Date: 2008-11-22 Impact factor: 10.793
Authors: Amy S Feldman; Yuan He; Martin L Moore; Marc B Hershenson; Tina V Hartert Journal: Am J Respir Crit Care Med Date: 2015-01-01 Impact factor: 21.405
Authors: Desmond W Cox; Joelene Bizzintino; Giovanni Ferrari; Siew Kim Khoo; Guicheng Zhang; Siobhan Whelan; Wai Ming Lee; Yury A Bochkov; Gary C Geelhoed; Jack Goldblatt; James E Gern; Ingrid A Laing; Peter N Le Souëf Journal: Am J Respir Crit Care Med Date: 2013-12-01 Impact factor: 21.405
Authors: Theodor F Griggs; Yury A Bochkov; Kazuyuki Nakagome; Ann C Palmenberg; James E Gern Journal: J Virol Methods Date: 2015-02-24 Impact factor: 2.014
Authors: Kohei Hasegawa; Jonathan M Mansbach; Yury A Bochkov; James E Gern; Pedro A Piedra; Cindy S Bauer; Stephen J Teach; Susan Wu; Ashley F Sullivan; Carlos A Camargo Journal: JAMA Pediatr Date: 2019-06-01 Impact factor: 16.193
Authors: Chris Mello; Esmeralda Aguayo; Madeleine Rodriguez; Gary Lee; Robert Jordan; Tomas Cihlar; Gabriel Birkus Journal: Antimicrob Agents Chemother Date: 2013-12-23 Impact factor: 5.191
Authors: Catherine Spickler; Julie Lippens; Marie-Kristine Laberge; Sophie Desmeules; Édith Bellavance; Michel Garneau; Tim Guo; Oliver Hucke; Pieter Leyssen; Johan Neyts; Fréderic H Vaillancourt; Anne Décor; Jeff O'Meara; Michael Franti; Annick Gauthier Journal: Antimicrob Agents Chemother Date: 2013-05-06 Impact factor: 5.191
Authors: Santtu Heinonen; Tuomas Jartti; Carla Garcia; Silvia Oliva; Cynthia Smitherman; Esperanza Anguiano; Wouter A A de Steenhuijsen Piters; Tytti Vuorinen; Olli Ruuskanen; Blerta Dimo; Nicolas M Suarez; Virginia Pascual; Octavio Ramilo; Asuncion Mejias Journal: Am J Respir Crit Care Med Date: 2016-04-01 Impact factor: 21.405
Authors: Amy S Feldman; Tina V Hartert; Tebeb Gebretsadik; Kecia N Carroll; Patricia A Minton; Kimberly B Woodward; Emma K Larkin; Eva Kathryn Miller; Robert S Valet Journal: Pediatr Allergy Immunol Pulmonol Date: 2015-06-01 Impact factor: 1.349